Duocarmycin A is a potent antitumor antibiotic belonging to the class of DNA minor groove-binding alkylating agents, originally derived from Streptomyces bacteria. It is primarily utilized in preclinical… Read more
Duocarmycin A is a potent antitumor antibiotic belonging to the class of DNA minor groove-binding alkylating agents, originally derived from Streptomyces bacteria. It is primarily utilized in preclinical research for its ability to selectively target and disrupt DNA replication in rapidly dividing tumor cells, making it a valuable cytotoxic payload in the development of advanced antibody-drug conjugates. This category includes high-quality reference standards of Duocarmycin A, as well as its related impurities, metabolites, and stable isotope-labelled compounds. These analytical materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and quality control. By providing reliable benchmarks for precise quantification and identity verification, these compounds support researchers in ensuring data integrity and regulatory compliance during the development of oncology therapies, stability testing, and advanced analytical studies using techniques such as LC-MS/MS.